Akari Therapeutics Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Samir Patel
Chief executive officer
US$9.8k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 20.5% |
| Management average tenure | no data |
| Board average tenure | 4.1yrs |
Recent management updates
Recent updates
CEO
Samir Patel (55 yo)
less than a year
Tenure
US$9,807
Compensation
Dr. Samir Rashmikant Patel, M.D. served as an Independent Director of Akari Therapeutics, plc since November 29, 2023 until May 1, 2024 and also serves as its Interim President, Chief Executive Officer and...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim President | less than a year | US$9.81k | 20.53% € 3.1m | |
| Director | less than a year | no data | no data | |
| Independent Director | 8.4yrs | US$71.78k | 0.084% € 12.5k | |
| Chairman | 9.2yrs | US$113.00k | 15.3% € 2.3m | |
| Independent Director | 1.4yrs | US$35.18k | 0% € 0 | |
| Independent Director | 6.8yrs | US$66.85k | 0.084% € 12.5k |
4.1yrs
Average Tenure
64yo
Average Age
Experienced Board: CLA's board of directors are considered experienced (4.1 years average tenure).